Literature DB >> 11588519

Signaling pathway and chronotropic action of parathyroid hormone in isolated perfused rat heart.

M Shimoyama1, K Ogino, Y Furuse, K Uchida, Y Kinugasa, Y Tomikura, O Igawa, I Hisatome, J P Bilezikian, C Shigemasa.   

Abstract

Parathyroid hormone (PTH) activates both adenylyl cyclase and phospholipase C via the PTH-1 receptor. We previously reported that PTH increased heart rate and that this effect was mediated via the pacemaker current (I f ). However, it has been reported that PTH exerts its chronotropic effect via an interaction with adrenergic receptors or via L-type calcium channels. Thus, the objective of the study was to elucidate the exact mechanism of the chronotropic effect of PTH. We tested whether its chronotropic effects could be abolished by inhibitors of the following systems in isolated perfused rat hearts: alpha-adrenergic (prazosin); beta-adrenergic (propranolol); angiotensin II (CV11974); endothelin-1 (TAK044); calcium channel (verapamil); adenylyl cyclase (miconazole); phospholipase C (U73122) or I f (CsCl). In addition, we measured the cyclic adenosine monophosphate level of the heart after PTH administration. Whereas prazosin, propranolol, CV11974, TAK044, verapamil, and U73122 did not inhibit the chronotropic effect of PTH, CsCl or miconazole suppressed it significantly. PTH increased the cyclic adenosine monophosphate level of the atrium but not the left ventricle. These results indicate that the chronotropic actions of PTH are mediated via selective activation of adenylyl cyclase to increase the I f current.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588519     DOI: 10.1097/00005344-200110000-00001

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

1.  Increased circulating concentrations of bioactive PTH 1-84 in patients with heart failure.

Authors:  D Gruson; T Lepoutre; S A Ahn; J M Ketelslegers; M F Rousseau
Journal:  J Endocrinol Invest       Date:  2012-02-28       Impact factor: 4.256

Review 2.  Can parathyroid hormone be used as a biomarker for heart failure?

Authors:  Sumeet Gandhi; Robert B H Myers
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

3.  Effect of intermittent versus continuous parathyroid hormone in the cardiovascular system of rats.

Authors:  Sanela Smajilovic; Rasmus Schaal-Jensen; Reza Jabbari; Una Smajilovic; Stig Haunso; Jacob Tfelt-Hansen
Journal:  Open Cardiovasc Med J       Date:  2010-03-31

Review 4.  Can the calcium-regulating hormones counteract the detrimental impact of pro-inflammatory damage-associated molecular patterns in the development of heart failure?

Authors:  Satenik H Adamyan; Knarik R Harutyunyan; Hermine T Abrahamyan; Drastamat N Khudaverdyan; Souren Mkrtchian; Anna S Ter-Markosyan
Journal:  J Investig Med       Date:  2021-05-05       Impact factor: 2.895

5.  Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links.

Authors:  A Fisher; W Srikusalanukul; M Davis; P Smith
Journal:  Clin Interv Aging       Date:  2013-02-25       Impact factor: 4.458

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.